Published in Neuroscience on January 20, 2010
The mysterious motivational functions of mesolimbic dopamine. Neuron (2012) 3.22
Chronic pain. Decreased motivation during chronic pain requires long-term depression in the nucleus accumbens. Science (2014) 1.90
Neurogenetics and pharmacology of learning, motivation, and cognition. Neuropsychopharmacology (2010) 1.45
The behavioral pharmacology of effort-related choice behavior: dopamine, adenosine and beyond. J Exp Anal Behav (2012) 1.33
Dissociation of hedonic reaction to reward and incentive motivation in an animal model of the negative symptoms of schizophrenia. Neuropsychopharmacology (2012) 1.26
Dopaminergic modulation of effort-related choice behavior as assessed by a progressive ratio chow feeding choice task: pharmacological studies and the role of individual differences. PLoS One (2012) 1.11
Effort-Based Decision Making: A Novel Approach for Assessing Motivation in Schizophrenia. Schizophr Bull (2015) 1.00
Alcohol and Caffeine: The Perfect Storm. J Caffeine Res (2011) 1.00
Differential effects of selective adenosine antagonists on the effort-related impairments induced by dopamine D1 and D2 antagonism. Neuroscience (2010) 0.91
Adenosine A2A receptors in the nucleus accumbens bi-directionally alter cocaine seeking in rats. Neuropsychopharmacology (2011) 0.90
Effort-related motivational effects of the pro-inflammatory cytokine interleukin 1-beta: studies with the concurrent fixed ratio 5/ chow feeding choice task. Psychopharmacology (Berl) (2013) 0.87
Changes in nucleus accumbens and neostriatal c-Fos and DARPP-32 immunoreactivity during different stages of food-reinforced instrumental training. Eur J Neurosci (2012) 0.86
Acute ethanol treatment upregulates Th1, Th2, and Hdc in larval zebrafish in stable networks. Front Neural Circuits (2013) 0.85
Lipopolysaccharide reduces incentive motivation while boosting preference for high reward in mice. Neuropsychopharmacology (2014) 0.85
Bupropion increases selection of high effort activity in rats tested on a progressive ratio/chow feeding choice procedure: implications for treatment of effort-related motivational symptoms. Int J Neuropsychopharmacol (2014) 0.84
Food reward in the obese and after weight loss induced by calorie restriction and bariatric surgery. Ann N Y Acad Sci (2012) 0.83
Stimulant effects of adenosine antagonists on operant behavior: differential actions of selective A2A and A1 antagonists. Psychopharmacology (Berl) (2011) 0.83
Effort-related motivational effects of the VMAT-2 inhibitor tetrabenazine: implications for animal models of the motivational symptoms of depression. J Neurosci (2013) 0.82
Effort Cost Computation in Schizophrenia: A Commentary on the Recent Literature. Biol Psychiatry (2015) 0.80
Effect of the adenosine A2A receptor antagonist MSX-3 on motivational disruptions of maternal behavior induced by dopamine antagonism in the early postpartum rat. Psychopharmacology (Berl) (2010) 0.79
c-Fos immunoreactivity in prefrontal, basal ganglia and limbic areas of the rat brain after central and peripheral administration of ethanol and its metabolite acetaldehyde. Front Behav Neurosci (2013) 0.78
The VMAT-2 inhibitor tetrabenazine alters effort-related decision making as measured by the T-maze barrier choice task: reversal with the adenosine A2A antagonist MSX-3 and the catecholamine uptake blocker bupropion. Psychopharmacology (Berl) (2014) 0.78
The VMAT-2 inhibitor tetrabenazine affects effort-related decision making in a progressive ratio/chow feeding choice task: reversal with antidepressant drugs. PLoS One (2014) 0.78
Effort-related motivational effects of the pro-inflammatory cytokine interleukin-6: pharmacological and neurochemical characterization. Psychopharmacology (Berl) (2016) 0.78
Neural substrates underlying effort, time, and risk-based decision making in motivated behavior. Neurobiol Learn Mem (2016) 0.78
Safety out of control: dopamine and defence. Behav Brain Funct (2016) 0.77
Choosing voluntary exercise over sucrose consumption depends upon dopamine transmission: effects of haloperidol in wild type and adenosine A2AKO mice. Psychopharmacology (Berl) (2015) 0.76
The effects of nucleus accumbens μ-opioid and adenosine 2A receptor stimulation and blockade on instrumental learning. Behav Brain Res (2014) 0.75
Perturbations in Effort-Related Decision-Making Driven by Acute Stress and Corticotropin-Releasing Factor. Neuropsychopharmacology (2016) 0.75
Assessment of a glycine uptake inhibitor in animal models of effort-related choice behavior: implications for motivational dysfunctions. Psychopharmacology (Berl) (2017) 0.75
Effort-related functions of nucleus accumbens dopamine and associated forebrain circuits. Psychopharmacology (Berl) (2007) 4.73
Beyond the reward hypothesis: alternative functions of nucleus accumbens dopamine. Curr Opin Pharmacol (2005) 2.57
Nucleus accumbens dopamine and the regulation of effort in food-seeking behavior: implications for studies of natural motivation, psychiatry, and drug abuse. J Pharmacol Exp Ther (2003) 2.10
Nucleus accumbens dopamine depletions make animals highly sensitive to high fixed ratio requirements but do not impair primary food reinforcement. Neuroscience (2001) 1.50
D1 or D2 antagonism in nucleus accumbens core or dorsomedial shell suppresses lever pressing for food but leads to compensatory increases in chow consumption. Pharmacol Biochem Behav (2001) 1.50
Nucleus accumbens dopamine depletions make rats more sensitive to high ratio requirements but do not impair primary food reinforcement. Neuroscience (1999) 1.45
The cannabinoid CB1 antagonists SR 141716A and AM 251 suppress food intake and food-reinforced behavior in a variety of tasks in rats. Behav Pharmacol (2003) 1.44
Negative regulation of T-cell adhesion and activation by CD43. Nature (1995) 1.44
How to contain generalized HIV epidemics? A plea for better evidence to displace speculation. Int J STD AIDS (2009) 1.42
Nucleus accumbens dopamine depletions alter relative response allocation in a T-maze cost/benefit task. Behav Brain Res (1996) 1.30
Effects of dopamine antagonists and accumbens dopamine depletions on time-constrained progressive-ratio performance. Pharmacol Biochem Behav (1998) 1.29
A neurochemical and behavioral investigation of the involvement of nucleus accumbens dopamine in instrumental avoidance. Neuroscience (1993) 1.21
Lesions in medial preoptic area and bed nucleus of stria terminalis: differential effects on copulatory behavior and noncontact erection in male rats. J Neurosci (1997) 1.21
The role of accumbens dopamine in lever pressing and response allocation: effects of 6-OHDA injected into core and dorsomedial shell. Pharmacol Biochem Behav (1998) 1.19
Nucleus accumbens dopamine depletions in rats affect relative response allocation in a novel cost/benefit procedure. Pharmacol Biochem Behav (1994) 1.18
Allosteric modulation of A(3) adenosine receptors by a series of 3-(2-pyridinyl)isoquinoline derivatives. Mol Pharmacol (2001) 1.18
Medical ethnobotany of the Teribes of Bocas del Toro, Panama. J Ethnopharmacol (2005) 1.14
The cannabinoid CB1 antagonist AM 251 produces food avoidance and behaviors associated with nausea but does not impair feeding efficiency in rats. Psychopharmacology (Berl) (2005) 1.13
The continuum of pulmonary developmental anomalies. Radiographics (1987) 1.12
Cannabinoid CB1 antagonists and dopamine antagonists produce different effects on a task involving response allocation and effort-related choice in food-seeking behavior. Psychopharmacology (Berl) (2007) 1.11
Different effects of nucleus accumbens and ventrolateral striatal dopamine depletions on instrumental response selection in the rat. Pharmacol Biochem Behav (1993) 1.10
Nucleus accumbens dopamine depletions and time-constrained progressive ratio performance: effects of different ratio requirements. Pharmacol Biochem Behav (1999) 1.07
A microdialysis study of nucleus accumbens core and shell dopamine during operant responding in the rat. Neuroscience (1998) 1.07
Isolation of immunoglobulin class switch variants from hybridoma lines secreting anti-idiotope antibodies by sequential sublining. J Immunol (1983) 1.07
Forebrain circuitry involved in effort-related choice: Injections of the GABAA agonist muscimol into ventral pallidum alter response allocation in food-seeking behavior. Neuroscience (2008) 1.05
Involvement of an aberrant right subclavian artery in dissection of the thoracic aorta: diagnostic and therapeutic implications. AJR Am J Roentgenol (1977) 1.03
Pharmacological characterization of performance on a concurrent lever pressing/feeding choice procedure: effects of dopamine antagonist, cholinomimetic, sedative and stimulant drugs. Psychopharmacology (Berl) (1994) 1.03
Adenosine A(2A) receptor blockade reverts hippocampal stress-induced deficits and restores corticosterone circadian oscillation. Mol Psychiatry (2012) 1.03
Effects of dopamine depletions in the medial prefrontal cortex on DRL performance and motor activity in the rat. Brain Res (1994) 1.02
A search for anti-viral properties in Panamanian medicinal plants. The effects on HIV and its essential enzymes. J Ethnopharmacol (1999) 1.01
Vascular dysgenesis associated with skeletal dysplasia of the lower limb. J Bone Joint Surg Am (1980) 1.01
Place navigation in rats is impaired by lesions of medial septum and diagonal band but not nucleus basalis magnocellularis. Behav Brain Res (1988) 1.00
Open field locomotor effects in rats after intraventricular injections of ethanol and the ethanol metabolites acetaldehyde and acetate. Brain Res Bull (2003) 1.00
The adenosine A2A antagonist KF17837 reverses the locomotor suppression and tremulous jaw movements induced by haloperidol in rats: possible relevance to parkinsonism. Behav Brain Res (2004) 0.99
Caffeine analogs: structure-activity relationships at adenosine receptors. Pharmacology (1991) 0.99
Epidemiology of Streptococcus pneumoniae and Staphylococcus aureus colonization in healthy Venezuelan children. Eur J Clin Microbiol Infect Dis (2010) 0.98
Substantia nigra pars reticulata is a highly potent site of action for the behavioral effects of the D1 antagonist SCH 23390 in the rat. Psychopharmacology (Berl) (2001) 0.98
Catalepsy induced by a blockade of dopamine D1 or D2 receptors was reversed by a concomitant blockade of adenosine A(2A) receptors in the caudate-putamen of rats. Eur J Neurosci (2001) 0.96
The "goose neck" of the endocardial cushion defect: anatomic basis. Chest (1974) 0.95
Potential anxiogenic effects of cannabinoid CB1 receptor antagonists/inverse agonists in rats: comparisons between AM4113, AM251, and the benzodiazepine inverse agonist FG-7142. Eur Neuropsychopharmacol (2009) 0.95
Kinetic evaluation of normal walking and jumping in cats, using a pressure-sensitive walkway. Vet Rec (2007) 0.94
Involvement of nucleus accumbens dopamine in the motor activity induced by periodic food presentation: a microdialysis and behavioral study. Brain Res (1992) 0.94
Water-soluble phosphate prodrugs of 1-propargyl-8-styrylxanthine derivatives, A(2A)-selective adenosine receptor antagonists. J Med Chem (2000) 0.94
Tremulous characteristics of the vacuous jaw movements induced by pilocarpine and ventrolateral striatal dopamine depletions. Pharmacol Biochem Behav (1997) 0.93
Composite graft replacement of the ascending aorta and aortic valve. Late follow-up with intra-arterial digital subtraction angiography. J Thorac Cardiovasc Surg (1988) 0.93
Adenosine A2A receptor antagonism and genetic deletion attenuate the effects of dopamine D2 antagonism on effort-based decision making in mice. Neuropharmacology (2012) 0.93
The novel cannabinoid CB1 antagonist AM6545 suppresses food intake and food-reinforced behavior. Pharmacol Biochem Behav (2010) 0.92
Tremulous jaw movements induced by the acetylcholinesterase inhibitor tacrine: effects of antiparkinsonian drugs. Eur J Pharmacol (1997) 0.92
The CB1 inverse agonist AM251, but not the CB1 antagonist AM4113, enhances retention of contextual fear conditioning in rats. Pharmacol Biochem Behav (2010) 0.92
Different behavioral functions of dopamine in the nucleus accumbens and ventrolateral striatum: a microdialysis and behavioral investigation. Neuroscience (1999) 0.92
Vacuous jaw movements and feeding deficits in rats with ventrolateral striatal dopamine depletion: possible relation to parkinsonian symptoms. J Neurosci (1991) 0.92
A detailed characterization of the effects of four cannabinoid agonists on operant lever pressing. Psychopharmacology (Berl) (1998) 0.91
Differential effects of selective adenosine antagonists on the effort-related impairments induced by dopamine D1 and D2 antagonism. Neuroscience (2010) 0.91
Synthetic 2-aroylindole derivatives as a new class of potent tubulin-inhibitory, antimitotic agents. J Med Chem (2001) 0.91
Non-healing gastric ulcer associated with Candida infection. Indian J Med Microbiol (2007) 0.90
Oral bioavailability of the novel cannabinoid CB1 antagonist AM6527: effects on food-reinforced behavior and comparisons with AM4113. Pharmacol Biochem Behav (2008) 0.90
Bioactive pyridoacridine alkaloids from the micronesian sponge Oceanapia sp. J Nat Prod (1998) 0.90
Paradoxical kinesia in parkinsonism is not caused by dopamine release. Studies in an animal model. Arch Neurol (1989) 0.89
Temporal measures of human finger tapping: effects of age. Pharmacol Biochem Behav (1998) 0.88
The impact of adenosine and A(2B) receptors on glucose homoeostasis. J Pharm Pharmacol (2006) 0.88
Impaired sexual response after lesions of the paraventricular nucleus of the hypothalamus in male rats. Behav Neurosci (1997) 0.88
The novel cannabinoid agonist AM 411 produces a biphasic effect on accuracy in a visual target detection task in rats. Behav Pharmacol (2005) 0.88
Slow phasic changes in nucleus accumbens dopamine release during fixed ratio acquisition: a microdialysis study. Neuroscience (2011) 0.87
Electrophysiological and behavioural evidence for an antagonistic modulatory role of adenosine A2A receptors in dopamine D2 receptor regulation in the rat dopamine-denervated striatum. Eur J Neurosci (2000) 0.87
Methylxanthines block antigen-induced responses in RBL-2H3 cells independently of adenosine receptors or cyclic AMP: evidence for inhibition of antigen binding to IgE. J Pharmacol Exp Ther (1991) 0.87
Different effects of haloperidol and extinction on instrumental behaviours. Psychopharmacology (Berl) (1986) 0.87
Intracerebroventricular administration of cannabinoid CB1 receptor antagonists AM251 and AM4113 fails to alter food-reinforced behavior in rats. Psychopharmacology (Berl) (2009) 0.86
Ethnobotanical inventory of medicinal plants used by the Guaymi Indians in western Panama. Part I. J Ethnopharmacol (1987) 0.86
Idiotope regulation by isotype switch variants of two monoclonal antiidiotope antibodies. J Exp Med (1984) 0.86
Serum chemistry and hematology values for anesthetized American bullfrogs (Rana catesbeiana). J Zoo Wildl Med (1997) 0.86
Locomotor stimulant effects of intraventricular injections of low doses of ethanol in rats: acute and repeated administration. Psychopharmacology (Berl) (2003) 0.86
Mild hypothermia: its effect on cardiac output and regional perfusion in the neonatal piglet. J Pediatr Surg (1980) 0.85
Tremulous jaw movements produced by acute tacrine administration: possible relation to parkinsonian side effects. Pharmacol Biochem Behav (1997) 0.85
The role of nucleus accumbens dopamine in the neurochemical and behavioral effects of phencyclidine: a microdialysis and behavioral study. Brain Res (1993) 0.85
Involvement of ventrolateral striatal dopamine in movement initiation and execution: a microdialysis and behavioral investigation. Neuroscience (1996) 0.85
The effects of haloperidol and clozapine on PCP- and amphetamine-induced suppression of social behavior in the rat. Pharmacol Biochem Behav (1994) 0.85
Behavioral effects of inhibition of cannabinoid metabolism: The amidase inhibitor AM374 enhances the suppression of lever pressing produced by exogenously administered anandamide. Life Sci (2004) 0.84
Rats with partial striatal dopamine depletions exhibit robust and long-lasting behavioral deficits in a simple fixed-ratio bar-pressing task. Behav Brain Res (1997) 0.84
Quetiapine (Seroquel) shows a pattern of behavioral effects similar to the atypical antipsychotics clozapine and olanzapine: studies with tremulous jaw movements in rats. Psychopharmacology (Berl) (2004) 0.84
The role of nucleus accumbens dopamine in responding on a continuous reinforcement operant schedule: a neurochemical and behavioral study. Pharmacol Biochem Behav (1993) 0.84
Lession on the hypothalamic arcuate nucleus by estradiol valerate results in a blockade of ethanol-induced locomotion. Behav Brain Res (2000) 0.84
Interactions between dopamine D1 receptors and gamma-aminobutyric acid mechanisms in substantia nigra pars reticulata of the rat: neurochemical and behavioral studies. Psychopharmacology (Berl) (2001) 0.83
Outcomes after intestinal transplantation: a single-center experience over a decade. Transplant Proc (2002) 0.83